All In Biotech

Free tool

FAERS Monitor: Janumet

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022044 or its brand name (Janumet, Metformin Hydrochloride, Sitagliptin Phosphate). Reports on generic versions are filed under their own applications.

Reports

19,518

Serious

13,277

68% of reports

Hospitalization

6,718

Death reported

2,052

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased1,318
  • diarrhoea1,214
  • nausea1,004
  • drug ineffective886
  • acute kidney injury823
  • fatigue821
  • vomiting706
  • weight decreased671
  • dyspnoea581
  • pancreatic carcinoma575
  • pancreatitis575
  • dizziness573
  • death569
  • lactic acidosis559
  • off label use559

Reports by year received

View as table
YearReports
200739
2008131
2009254
2010384
2011537
2012839
20131,225
20141,686
20152,188
20161,897
20171,497
20181,634
20191,481
20201,378
20211,149
2022909
2023801
2024664
2025505
2026320

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,641 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pancreatic carcinomaSignal57521.920.211,219
lactic acidosisSignal55918.917.49,314
pancreatitisSignal57511.810.95,650
blood glucose increasedSignal1,3187.67.27,542
acute kidney injurySignal8235.85.43,288
weight decreasedSignal6712.62.4663
diarrhoeaSignal1,2142.01.9651
vomiting7061.61.5170
nausea1,0041.41.3103
dizziness5731.21.127
fatigue8211.11.114
dyspnoea5811.11.06
drug ineffective8860.70.799
death5690.70.769
off label use5590.70.682

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.